Dengue vaccines regulatory pathways: a report on two meetings with regulators of developing countries.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21364969.
- Also identified by DOI 10.1371/journal.pmed.1000418 and PMC identifier 3042996.
- Licence recorded as CC0.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Richard Mahoney and colleagues summarize two recent meetings convened by the Pediatric Dengue Vaccine Initiative and the Developing Countries' Vaccine Regulators Network on regulatory issues that need to be addressed before licensing dengue vaccines.
Medical subject headings
- Clinical Trials as Topic
- Dengue
- Dengue Vaccines
- Developing Countries
- Drug and Narcotic Control
- Drug-Related Side Effects and Adverse Reactions
- Government Regulation
- Vaccination